TICAGRELOR 90 MG
Ticagrelor is a medication used to prevent blood clots in people with acute coronary syndrome (ACS) or a history of heart attack or stroke. It belongs to a class of drugs known as antiplatelet agents, which help to prevent platelets in the blood from sticking together and forming clots.
Active Ingredients
The active ingredient in Ticagrelor is Ticagrelor 90 mg.
Pharmacological Properties
Ticagrelor works by inhibiting the P2Y12 receptor on the surface of platelets, which prevents them from becoming activated and forming blood clots. It has a rapid onset of action and is more effective than older antiplatelet medications.
Indications
Ticagrelor is indicated for the prevention of cardiovascular events in patients with ACS, including unstable angina and non-ST elevation myocardial infarction (NSTEMI), as well as those with a history of heart attack or stroke.
Contraindications
Ticagrelor is contraindicated in patients with a history of intracranial hemorrhage, active bleeding, severe liver disease, or hypersensitivity to Ticagrelor or any of its components.
Dosage
The usual dose of Ticagrelor is 90 mg taken orally twice daily with or without food. It is important to follow the prescribed dosing regimen and not to exceed the recommended dosage.
Side Effects
Common side effects of Ticagrelor may include bleeding, shortness of breath, dizziness, bruising, and gastrointestinal disturbances. Contact your healthcare provider if you experience any severe or persistent side effects.
Drug Interactions
Ticagrelor may interact with other medications such as anticoagulants, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain antidepressants. Inform your healthcare provider about all the medications you are taking to avoid potential drug interactions.
Patient Counseling
Patients taking Ticagrelor should be advised to report any signs of bleeding, chest pain, or difficulty breathing immediately. It is important to follow the prescribed treatment plan and attend regular follow-up appointments.
Clinical Evidence
Clinical studies have demonstrated the efficacy of Ticagrelor in reducing the risk of cardiovascular events in patients with ACS. It has been shown to be more effective than older antiplatelet drugs with a lower risk of adverse events.
Frequently Asked Questions
1. What is Ticagrelor used for?
Ticagrelor is used to prevent blood clots in patients with acute coronary syndrome (ACS) or a history of heart attack or stroke.
2. How should Ticagrelor be taken?
The usual dose of Ticagrelor is 90 mg taken orally twice daily with or without food as prescribed by your healthcare provider.
3. What are the common side effects of Ticagrelor?
Common side effects of Ticagrelor may include bleeding, shortness of breath, dizziness, bruising, and gastrointestinal disturbances. Contact your healthcare provider if you experience any severe or persistent side effects.
4. Can Ticagrelor interact with other medications?
Yes, Ticagrelor may interact with other medications such as anticoagulants, NSAIDs, and certain antidepressants. Inform your healthcare provider about all the medications you are taking to avoid potential drug interactions.
5. When should I seek medical help while taking Ticagrelor?
You should seek immediate medical attention if you experience signs of bleeding, chest pain, or difficulty breathing while taking Ticagrelor.
6. Is Ticagrelor safe for everyone?
Ticagrelor may not be safe for patients with a history of intracranial hemorrhage, active bleeding, severe liver disease, or hypersensitivity to Ticagrelor or any of its components. Always consult your healthcare provider before starting this medication.
For further information and personalized guidance, please consult your healthcare provider.
